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5Introduction
Procurement of inferior quality products is not cost-effective, but, most
importantly, it contradicts the concept of harm reduction itself.
Implementing NGO, Georgia 
The Global Fund to Fight AIDS, Tuberculosis and Malaria, the world’s largest donor
for harm reduction services, has contributed, since its creation in 2002, more than
US$1 billion in grants for programs that address the HIV prevention needs of inject-
ing drug users.1 In Eastern Europe and Central Asia, where the HIV epidemic is con-
centrated largely among injecting drug users, sex workers, and their sexual part-
ners,2 countries have used Global Fund resources to begin and scale up essential
harm reduction services, including needle exchange programs that provide clean
and sterile needles to injection drug users and buprenorphine and methadone pro-
grams that reduce cravings for illicit opiates. 
In Armenia, Georgia, Russia, and Tajikistan, a significant share of the Global
Fund’s commitment of more than US$283 million for HIV and AIDS programs is
focused on prevention and treatment for injection drug users. In this region, as else-
where, needle and syringe programs have proven effective in reducing needle shar-
ing and other risks of HIV transmission, and they help introduce drug users to other
health care services, including voluntary counseling and testing, HIV treatment, and
hepatitis C (HCV) and sexually transmitted infection (STI) diagnosis and treatment.3
The cornerstone of effective harm reduction programs is trust between service
providers and drug users. Providing high-quality services and the supplies that drug
users need and want to inject more safely is critical for establishing this rapport.
Providing syringes and needles that are of bad quality or inappropriate for use, on
the other hand, undermines the ability of these services to engage drug users and
reduces the effectiveness of HIV prevention programs. Likewise, since many drug
users inject once, or multiple times, a day, ensuring their consistent access to clean
needles is important, and shortages or interruptions in the availability of supplies
can be damaging. 
This report evaluates the procurement of supplies for needle and syringe pro-
grams with resources provided by the Global Fund in four countries of Eastern
Europe and Central Asia: Armenia, Georgia, Russia, and Tajikistan. The Global Fund
is the sole source of external funding for the procurement of supplies needed for
harm reduction programs in these countries, yet the quality and range of supplies
purchased with Global Fund resources has been mixed. 
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In all four countries, the supplies procured to increase the safety of injection and
reduce HIV transmission is limited to syringes, needles, and possibly alcohol swabs
and sterile water; other essential commodities, such as filters, cookers, and antibiotic
ointment, are procured sporadically, or not at all. At various times, needles and
syringes have been procured that drug users do not find usable because, for exam-
ple, they may be the wrong size or type. In most of the countries surveyed, NGOs
have experienced delays or interruptions in receiving supplies. There is a general
lack of communication and consultation on procurement of supplies between the
principal recipients that directly receive Global Fund grants and the subrecipient
NGOs that implement the grants. 
Similar concerns have been reported in other countries in the region. In
Ukraine, for example, a meeting was recently convened of stakeholders concerned
that the needles and syringes being distributed for harm reduction programs were
inadequate. Principal recipients, the Global Fund secretariat, and the NGO subrecip-
ients all need to do more to ensure that the procured supplies are of good quality and
meet drug users’ needs. 
In this study, we assess the quality of harm reduction supplies being procured
with Global Fund resources, examine the decision-making and procurement
processes at the country level, highlight good procurement practices, and provide
recommendations for improving the quality of supplies and, ultimately, harm reduc-
tion services.  
Note: Procurement practices described in this report have changed since
research was conducted in 2008.  In Tajikistan, for example, the principal recipi-
ent—following review of a draft of this report—sent trucks to recover materials
deemed inadequate from at least one Global Fund subrecipient, and delivered nee-
dles and syringes of the kind desired by program beneficiaries. In Russia, Global
Fund support for a number of harm reduction programs supported in Round 3
ended. The Russian government reneged on a promise to provide support, causing
staff layoffs and closure.
HIV and AIDS in Eastern Europe and Central Asia
The estimated number of people living with HIV in Eastern Europe and Central Asia rose
to 1.5 million in 2007; almost 69 percent of those infected live in the Russian Federation.4
Of the new HIV cases reported in the region in 2006 for which information is available
on the mode of transmission, about 62 percent were attributed to injecting drug use.
The overlap of sex work and injecting drug use features prominently in the region’s epi-
demics: recent studies have found that between 30 percent and 40 percent of sex workers
report that they have also injected drugs.5
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The research team was comprised of three experts (a public health specialist, a policy
expert, and a procurement expert) and four country analysts. An initial desk review
included publicly available information on HIV and AIDS epidemiology, Global
Fund project implementation, and procurement practices in the four target coun-
tries. All six principal recipients of the current Global Fund HIV and AIDS grants
participated in the assessment. In addition, the research team surveyed 29 NGO
subrecipients:
t Four NGOs from Armenia (from two regions)
t Five NGOs from Georgia (from two regions) 
t Five NGOs from Tajikistan (from four regions)
t Fifteen NGOs from Russia (from 13 regions) 
Most NGOs were directly involved in distribution of harm reduction supplies to drug
users, sex workers, and men who have sex with men; some NGOs were staffed by
drug users, or former drug users. Data was collected from the NGOs through self-
administered and interviewer-administered questionnaires from August to
November, 2008. Additional information was collected during informal interviews
with the representatives of NGOs that provide harm reduction services and during a
round table meeting in Chisinau, Republic of Moldova, in April 2009. 
Limitations
This study had a very limited scope and the data is mostly of a qualitative nature 
collected primarily from principal recipients and a subset of implementing NGOs.
While the data provides a snapshot of common themes and challenges with procure-
ment, it is neither random nor representative, and the findings cannot be directly
extrapolated to other countries and projects. The research focused primarily on the
quality of syringes and needles and does not address condoms or methadone (which
is being procured with Global Fund resources in Georgia). Buprenorphine programs
are not being implemented in any of the four countries. Despite the limitations, the
concerns experienced by both NGOs and principal recipients and the recommenda-
tions for addressing these concerns provide useful lessons for other countries imple-
menting harm reduction projects financed by the Global Fund. 
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Harm Reduction and Harm Reduction Supplies
Harm reduction is a public health approach that includes information and education,
especially about reducing risk through outreach work; needle and syringe exchange pro-
grams; treatment of drug dependence, in particular opiate substitution therapy; voluntary
confidential counseling and testing for HIV; provision of HIV and AIDS treatment, care,
and support; prevention of sexual transmission of HIV, treatment of sexually transmitted
infections, and condom distribution programs; and general health care interventions
including diagnosis, treatment, and, where relevant, vaccination for hepatitis B and C,
overdose management, and wound care.6
Essential harm reduction supplies include the following: 
t Injection equipment: needles and syringes, such as insulin needles with syringes,
“Groin” needles, “Blue Head” needles, tuberculin syringes, etc.
t Safer shooting kits: alcohol prep pads or swabs used before injection to clean
away dirt and bacteria from the injection site; bandages used to cover open sores;
3-in-1 antibiotic ointment that helps healing wounds, abscesses, and open sores,
usually applied after injection; cotton pellets used as filters when drawing
liquefied drugs into syringes; cookers used as containers to dissolve drugs,
usually in water; antiseptic tissues for general hygiene.
t Bleach kits: bleach used to clean needles during sharing or reuse; sterile water for
cooking the drugs and for rinsing needles after bleaching.
t Safer sex supplies: male condoms, which are best known for their role in safer
sex, but can also be used as a tie-off strap for finding and enlarging veins before
injecting; female condoms; dental dams used as a protection against STIs
(transmitted via oral, anal, or vaginal route); and lubricants (some injecting drug
users also use lubricant to keep the rubber on the plunger of the syringe from
degrading). 
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Harm Reduction in 
Armenia, Georgia, 
Russia, and Tajikistan 
The Global Fund to Fight AIDS, Tuberculosis and Malaria is an international financ-
ing mechanism dedicated to raising and disbursing additional resources to prevent
and treat the three diseases. It funds only interventions that are based on evidence
and good practice; funding is disbursed based on a program’s performance; and the
involvement of civil society (including groups of affected populations) in designing
funding proposals and implementing programs is required.7 Since its creation in
2002, the Global Fund has committed US$15.6 billion in 140 countries to support
large-scale prevention, treatment, and care programs.8 In Eastern Europe and
Central Asia, the Global Fund has quickly become the most important donor for HIV
and AIDS prevention, treatment, care, and support. 
In Armenia, Georgia, Russia, and Tajikistan, the Global Fund has committed
more than US$283 million in grants to fight HIV and AIDS. The grants ranged from
US$2.4 million (Tajikistan Round 1) to US$119.9 million (Russia Round 4) for proj-
ects to be implemented over a five-year period. All grants include harm reduction
interventions, which are important components of the programs.9 Although there
are a number of organizations active in harm reduction in the four countries, the
Global Fund is currently the only source of external funding for the procurement of
harm reduction supplies.
The amount of funding budgeted for harm reduction supplies varies from less
than 1 percent of grant funds in Armenia to more than 50 percent for Tajikistan’s
US$2.5 million round 1 grant, which focused on high-risk groups. The median per-
centage of grant funds used for purchasing supplies in the four countries is 9.6 per-
cent. While the overall proportion of spending on harm reduction supplies is rela-
tively small—mostly because the supplies are inexpensive and the number of drug
users accessing services is limited—the provision of harm reduction services and
supplies plays a vital role in HIV prevention and treatment efforts. 
During the six years of Global Fund support, substantial progress has been
achieved in the four countries in increasing the scale of harm reduction interven-
tions. In Armenia, for example, the number of drug users reached with harm reduc-
tion services has reportedly increased from almost 200 in 2005 to 1,246 at the end
of 2008, according to the Global Fund’s performance report.10 In Georgia’s round 
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2 project, harm reduction services expanded from approximately 1,000 drug users
in 2003 to more than 21,000 in February 2008.11 The Global Fund rates the perform-
ance of the projects in all four countries as adequate, or meeting or exceeding expec-
tations. However, NGOs working in these countries have repeatedly raised concerns
that the quality of supplies provided to them with Global Fund resources is inade-
quate or inconsistent and that this problem with quality may be limiting the effec-
tiveness of their programs. 
Table 1. Total funding amounts per grant and planned funding for procurement of
harm reduction supplies in HIV/AIDS Global Fund projects in Armenia, Georgia,
Russia, and Tajikistan.
Country Round        Total grant amount               Funding for procurement of supplies
                                (5 years), US$         Absolute amount, US$ % of total grant amount
Armenia* 2 8,087,459 68,000 0.8
Georgia** 2 12,125,644 1,211,122 10.0
Georgia 6 11,385,859 434,454 3.8
Russia 3 88,742,354 10,321,442 11.6
Russia 4 119,873,915 666,126 0.6
Russia 5 16,020,000*** 2,070,000**** 12.9
Tajikistan 1***** 2,425,245 1,353,325 56.0
Tajikistan 4 8,076,667 605,711 7.5
Tajikistan 6 12,096,246 3,487,969 28.8
TOTAL $278,833,389***** $20,218,149 7.4% (average)
* Armenia has received two bridge funding grants of $1,703,712 and $866,144; the proportion of the
budget dedicated to the procurement of harm reduction supplies was not available at the time 
of this research. Bridge funding is provided to countries eligible for rolling continuation channel
funding to continue or scale up existing grants, so as to ensure the continuation of programs. 
** Georgia has received bridge funding in the amount of $2,252,034; the proportion of the 
budget dedicated to the procurement of harm reduction supplies was not available at the 
time of this research.
** Grant of 11,439,594 euros (approximately US$16.02 million)
*** 1,477,000 euros (approximately US$2.07 million)
**** Project completed
***** With bridge funding, total grant commitments in the four countries total US$283,655,279. 
Sources: As budgeted in project proposals, reported by principal recipients and on file with the Global 
Fund Secretariat. These figures include actual and budgeted expenditures. 
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Key Issues in 
Quality and Supply
Our NGO is a “self-organization” [of drug users], therefore, we better under-
stand our beneficiaries’ complaints and problems in terms of insufficient
quality and quantity of particular harm reduction products such as syringes
and needles. We are very much concerned not to lose their trust by perma-
nently disappointing them. 
Implementing NGO, Georgia 
Poor quality syringes and needles
Of the NGOs surveyed, 45 percent, mostly in Georgia and Tajikistan, indicated that
drug users had complained several or many times about the supplies while 55 per-
cent received either no or few complaints. Sixty-four percent of the NGOs said that
drug users complained about the poor quality of the supplies they received, while 41
percent said the supplies received were not appropriate for safer injection drug use.
Of the NGOs that indicated that they had few or no problems with the supplies, in
9 out of 11 cases the principal recipients were nongovernmental organizations, most-
ly in Russia and Armenia. 
Clients from our project took new needles that they had gotten from the [principal recip-
ient] and traded them at the pharmacy at two for one—two new, unusable needles for
one of the quality they needed from the pharmacy.  
Implementing NGO, Tajikistan
In Tajikistan, four out of the five NGOs that we surveyed indicated that they had
experienced serious problems with the quality of the supplies that they had received
from the Global Fund principal recipient. One NGO said, “Needles are blunt and
often bend or break and rust; the pistons leak; the rubber of the piston decomposes
if the drug is not injected immediately. . . the needle’s diameter is too small and 
the drug gets stuck.” Another NGO reported that because drug users couldn’t use
the supplies they had been given and their complaints about the poor quality result-
ed in no change, they refused to continue distributing the syringes provided by the
Global Fund. 
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In Russia, where NGOs receive some centrally procured products and procure
some directly, fewer drug users complain about the quality of supplies. However, one
subrecipient indicated that, “in some cases and regions, centrally supplied goods are
of lower quality than those available on the market. The goods are acceptable until
the clients have a negative experience, for example, jammed piston, blunt tip, torn
condom, etc.” In Georgia, on the other hand, the majority of NGOs complained that
they had received poor-quality “scalp-vein” needles and insulin syringes, which are
in high demand by drug users who inject buprenorphine or heroin. 
In Armenia, most of the problems with quality occurred during procurements
in the first two years of the project. One Armenian NGO reported: “The syringes
supplied at that time were without rubber padding and with needles that were too
thick and had an insufficient angle at the point.” In response to these complaints,
the principal recipient established a procedure to pretest products with drug users
and sex workers to make sure that they were appropriate and met their needs before
procuring them in large quantities. By all accounts, this procedure has worked well,
and NGOs, as well as their clients, report far fewer concerns. 
In the first two years, we had lots of problems. In the first year, we had syringes with very
thick needles (that the users didn’t want). The second year, the syringes had no rubber
plungers, so we had to dismantle them and reassemble them. In the third year, we
reached an understanding: before the contract is signed, the contractor supplies samples
and the principal recipient distributes them to the outreach workers, who test them with
the clients. It continues this way. They ask me how many supplies I need for the next
year—they send samples, and they ask if we approve or disapprove of them. Do I need
insulin syringes or bigger ones? We have a strong relationship.
Implementing NGO, Armenia
Principal recipients noted that, at times, the supplies that they received were not
what they expected. In Russia, for example, suppliers did not have the requested 
supplies in stock when one principal recipient placed an order. The principal recipi-
ent agreed to substitutions based upon the suppliers’ assurances that the products
met the technical specifications in the tender documents, but it turned out that the
substations were of poorer quality and did not meet drug users’ needs. 
When we first proceeded to centralized procurement, at the moment the supplies had to
go to the regions, the suppliers said they didn’t have the syringes but they had something
similar with 100 percent the same technical specifications.  We had already had some
delays, so we agreed.  When the syringes arrived, they had black washers at the bottom,
and the users couldn’t see their blood as it was being drawn up. Now we have learned
our lessons and check the supplies with people before we order or send them.
Principal recipient, Russia
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Similarly, the principal recipient in Georgia has had experiences where apparently
reliable suppliers submitted a full range of requested documentation including inter-
national certificates, laboratory certificates of analyses, and confirmation of prod-
ucts’ parameters. However, when the products were delivered they were not of the
stated quality or specifications and the supplies were refused by drug users. 
Frequent changes in the narcoscene [drug market], lately caused by law-enforcement
measures, require rapid adjustments to [the supplies]. Unfortunately, current [procure-
ment] methods do not allow us to meet urgent needs of our beneficiaries due the shortage
of particular products.
Implementing NGO, Georgia
In each of the four countries, drug consumption patterns change frequently, based
upon the availability and cost of various drugs. Insulin syringes (about 1 ml) are used
for injecting heroin or subotex, for example, while 2 ml syringes are used for inject-
ing amphetamines, and 5 ml or 10 ml syringes are used for other types of opiates.
Yet, many of the Global Fund projects have not built in sufficient flexibility to
respond to changes in drug trends so the supplies that NGOs receive do not always
meet drug users’ needs. 
In Georgia, NGOs noted that they were experiencing shortages of 2 ml syringes
at the time the research was conducted. In Russia, one NGO noted that “60,000
needles of only one size are delivered when clients need, for example, syringes of 
1 ml instead of 2 ml.” Likewise, an NGO in Tajikistan reported that “the principal
recipient procures mostly 2 ml syringes because these are the most-used syringes for
heroin. But sometimes clients require 1 ml syringes, if, for example, they are new
heroin users or they are injecting pure heroin, or larger syringes if the drug market
changes due to drought and some IDUs switch to opiates.” 
Drug user’s practices and preferences are also not always taken into account in
procurement decisions. In Tajikistan, for example, an NGO noted that “many users
prefer to receive separate syringes and needles but these were not available.” 
In Russia, the Open Health Institute and the Russian Harm Reduction Network,
have addressed this issue by procuring some supplies centrally, and giving subrecip-
ients the flexibility to procure small quantities of supplies directly in order to
respond to changing needs, while the Russian Health Care Foundation’s subrecipi-
ents procure all supplies themselves. 
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Limited Range of Supplies
NGOs have asked for injection water in plastic bottles (it’s easy to carry it in the pocket),
but have received glass bottles that beneficiaries are less willing to take.
Implementing NGO, Tajikistan 
A full range of supplies is needed to increase the safety of injecting and reduce the
risk of HIV and HCV transmission. These include sterile water, alcohol swabs, cook-
ers, antibiotic ointment, and other products defined earlier in this report. However,
in most countries Global Fund principal recipients do not procure such supplies,
often because their Global Fund proposals did not include funding for them. 
In Russia, the Open Health Institute and Russian Harm Reduction Network
procure syringes and needles and condoms, and provide funding to NGOs to obtain
additional supplies, such as alcohol swabs and bleaches. However, even there NGOs
felt constrained by the range of products they were able to procure; some of the sup-
plies they want, such as sterile cookers and lubricants in single-use packets, are not
readily available in Russia. 
Harm reduction NGOs in Tajikistan noted that initially only syringes, needles,
and condoms were available. Starting in August 2008, NGOs also began receiving
alcohol swabs, sterile water, and disposal containers for needles and other sharp
objects. However, these supplies have not apparently reached all implementing
NGOs:
Today we have 2 ml and 5 ml syringes, two sizes.  Regarding the alcohol pads, not every-
body receives them for some reason.  Clean water for injection also exists, but not every-
one receives them.  [Sharps] containers—not everyone receives them. 
Implementing NGO, Tajikistan
Four out of the five Tajik NGOs surveyed recommended extending the package of
services available to drug users even further to include utensils for processing drugs,
spoons, tourniquets, and appropriate information and education materials. 
In Georgia, the principal recipient procures syringes, needles, and condoms.
Alcohol swabs and sterile water are procured by NGOs. NGOs reported that they had
advocated for expanding the range of supplies available, but had so far not met with
success. In Armenia, the principal recipient also procures only syringes, needles,
and condoms. One NGO explained: “The principal recipient procures syringes and
needles and condoms. Alcohol pads for safer injections are procured by our organi-
zation. Why did it happen? To the best of my knowledge, these alcohol pads are not
in the Global Fund application.” 
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Delays and interruptions in receiving supplies
The principal recipient should prevent unacceptable delays in almost all components of
the harm reduction program. Otherwise, the implementing organizations may reconsider
their participation in this program, as these interruptions substantially affect their pres-
tige in general and particularly among the user community. 
Implementing NGO, Georgia
In Georgia, all of the NGOs we surveyed had experienced delays in receiving 
supplies, hampering the ability of NGOs to implement programs effectively and
according to schedule. In Armenia, a recent gap in Global Fund funding meant that
NGOs experienced a shortage of supplies. Delays in procurement in Tajikistan also
slowed down project implementation and caused NGOs to experience interruptions
in supplies: “For four or five months we’re waiting for supplies, writing letters 
back and forth.” 
Storage and Delivery of Supplies
In Tajikistan, NGOs noted that they experienced difficulty transporting and storing
supplies, particularly since they did not receive funding to cover these expenses: “We
get a delivery once in six months—which means that we need guards for supplies,
storage, none of this is taken into account. This means additional costs and addition-
al funds.” NGOs providing harm reduction activities are only provided supplies by
the principal recipient and do not receive any funds for handling, delivery, and stor-
age. Lacking funds for appropriate storage and security, NGOs often store harm
reduction goods in their offices at the risk of getting into trouble with law enforce-
ment agencies since they are not authorized to store large quantities of syringes and
needles. 
Inflexibility, Despite Changing Needs
NGOs in all four countries have faced other challenges in providing needle exchange
services. NGOs in Tajikistan reported that supplies were procured to cover one year
of implementation, which meant that the poor quality of supplies could not be easily
addressed during that period.
Several NGOs from all countries also pointed out that harm reduction activities
in the region have changed over the last decade, in terms of composition of the target
groups, substances consumed, nature of public drug markets, and risk behaviors.
This requires that traditional approaches be modified and innovative approaches be
employed to keep in contact with drug users and carry out prevention activities suc-
cessfully. However, NGOs reported that Global Fund programs allowed little flexibil-
ity, thus restricting them from trying new approaches. 
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Good Practice: Moldova
The procurement of harm reduction supplies is centralized to ensure high quality and
the best prices. The procurer uses a list of national prequalified suppliers. The procure-
ment is done once a year and detailed specifications for every product are developed with
the participation of beneficiaries. 
If the harm reduction product is new or unknown on the market, the procurer pretests
it by distributing a small quantity among project sites and collecting feedback over a
three-month period to ensure quality and appropriateness. 
The contract is based on continuous supply: it includes the total amount of the contract
and price per unit, but does not stipulate the quantities to be purchased and delivered.
The supplier distributes the goods to all harm reduction sites around the country at the
request of the sub-recipients. This contract provides flexibility and allows the adjustment
of quantities based on needs, permits quick reaction to requests, and avoids other addi-
tional costs, such as for supplemental transportation and storage. 
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Procurement Laws, 
Policies, and Practices
National procurement laws and policies
The public procurement laws and regulations in all four countries provide for the
implementation of the key principles of good procurement, such as fostering econ-
omy and efficiency and curbing abuses through maximizing competition, according
fair treatment to suppliers and contractors, and enhancing transparency and objec-
tivity in procurement decisions. 
In Armenia, Georgia, and Tajikistan, the public procurement laws provide a gen-
eral framework for action, with regulations that provide greater guidance. The law in
Russia presents a very detailed description of procedures that public procurers must
follow, such as the mandatory use of ceiling prices and traditional reverse auctions
as a preferred procurement method. 
The laws and regulations in all countries set rules and procedures that are com-
mon for all sectors; at the same time, these common rules may not meet the specific
needs of procurers of health products, such as the need to ensure the timely and
uninterrupted supply of quality products to the people in need. 
The procurement legislation and regulations in all countries have provisions for
assuring quality of goods, works, or services purchased. However, price is the dom-
inant criterion for awarding contracts in public procurement in all of the four coun-
tries. Except in a few cases related to emergency situations, the procurement laws
and regulations do not permit the use of less competitive methods or allow devia-
tions from standard procedures for procurement of pharmaceuticals and health
products in any of the four countries. 
The specification of brand names and trademarks in tender documents is forbid-
den in all four countries, which is a normal procurement practice.
Global Fund Procurement Requirements 
In grant agreements with principal recipients, the Global Fund requires that princi-
pal recipients use competitive procurement methods and procure the lowest-priced
commodities, with sufficient consideration given to quality, except in the case of
small-scale or emergency orders. The Global Fund also encourages procurement of
the largest possible quantities that are reasonable, according to the requirements of
the project, in order to achieve economies of scale.12
For nonpharmaceutical health products, including syringes, needles, and con-
doms, the Global Fund recommends that principal recipients select from lists of pre-
qualified suppliers, products approved by regulatory authorities , where they exist, or
products that are in line with national standards.13
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All principal recipients must submit a procurement and supply management
plan to the Global Fund for approval before procurement can begin. 
Principal Recipients’ Procurement Rules and Practices
The legal status of the principal recipients differs in each of the four countries: in
Armenia, the principal recipient is an international NGO, World Vision; in Georgia,
it is the Project Implementation Unit under the Ministry of Health; in the Russian
Federation, two principal recipients are national NGOs (the Open Health Institute
and the Russian Harm Reduction Network) and one is a noncommercial partnership
(the Russian Health Care Foundation); and in Tajikistan, the principal recipient is
the United Nations Development Program. In the four countries, public procure-
ment policies, laws, and regulations apply in full only to the Georgian Ministry of
Health; however, governmental subrecipients of the Russian Health Care
Foundation must also comply with public procurement laws and policies. The
remaining principal recipients undertake procurement in line with their own regu-
lations, which, to varying extents, need to comply with national policies, as well as
the Global Fund’s own procurement policies. 
The principal recipients use different methods to procure harm reduction sup-
plies, including international and national competitive bidding, national shopping,
and direct contracting. The decisions regarding which method will be used are made
based on the procurement guidelines used by each principal recipient. In Tajikistan,
for example, the principal recipient procures either through international tender or
through procurement agents with whom they have long term agreements, such as
UNICEF and UNFPA.
All principal recipients except the Russian Harm Reduction Network publicly
advertise the procurement notices for competitive bidding on their organizational
websites and in local newspapers. The Russian Harm Reduction Network procures
syringes, needles, and condoms from one supplier that was selected to supply prod-
ucts for the duration of the project, in accordance with the project’s Procurement
and Supply Management Plan.
None of the principal recipients in the four countries restrict the participation of
foreign companies in bidding for contracts. However, access to tender documents by
potential foreign suppliers (contractors) is limited as this information is available
almost exclusively in local languages. In the case of health procurement, this may be
an important barrier in obtaining high-quality products or services. The small quan-
tities of supplies procured in these countries may also result in limited interest from
foreign vendors. 
Principal recipients use prequalification in varying ways as a basis for selecting
suppliers who can submit bids; prequalification is used by default by the Georgian
principal recipient. Systems that require all bidders to be prequalified could prevent
new suppliers from engaging in the procurement process. 
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Challenges in the 
Procurement Process
Principal recipients and representatives of implementing NGOs gave a number of
reasons for the often inappropriate or poor quality of harm reduction supplies.
These included insufficient attention to the beneficiaries’ needs and expectations by
the procurement entity; the lack of participation of drug users or harm reduction
NGO representatives in developing Global Fund proposals and technical specifica-
tions and evaluating bids; the use of price as a sole or heavily predominant criterion
when awarding supply contracts, to the detriment of quality criteria; rigid centralized
procurement processes that do not allow for flexibility in choice or quantities of
products when faced with changes in drug consumption patterns; and delays in con-
tracting, deliveries, or other problems with contracts administration by the principal
recipients. These issues are explored further below. 
Global Fund Proposals: Range of Products and Target Group Size
Estimations
Sometimes I don’t want to sign the Global Fund proposals, but the Minister of Health
will say, “Who is this person?” He will say, “Who is this person and why is he a problem?”
Here it is very hard—there is little time, you have no chance to review the proposal—
you sign the proposal and that’s it. Or you don’t and that means there is no consensus
and the proposal doesn’t go.
NGO representative on the country coordinating mechanism, Tajikistan 
In most cases, the proposals submitted to the Global Fund specify the types, quanti-
ties, and budget for products to be procured. After grant agreements are signed
between principal recipients and the Global Fund, principal recipients have very lit-
tle flexibility to make changes to work plans and budgets. For this reason, the
process of developing proposals to the Global Fund is, perhaps, the most critical
entry point for ensuring that a full range of quality products that meet the needs of
drug users are supplied. 
Proposals to the Global Fund must be developed by country coordinating mech-
anisms (CCMs), multistakeholder bodies that are also charged with overseeing grant
implementation. The Global Fund requires the participation of NGOs and people liv-
ing with or affected by the three diseases on CCMs, and strongly recommends that
key affected communities are also members. The Global Fund also requires that the
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processes for developing proposals are documented and transparent and allow for
broad involvement of NGOs, key affected populations, and other interested groups.14
When CCMs are designing harm reduction programs, the involvement of NGOs
that provide outreach and needle exchange services to drug users is essential for
input on the types of products required based upon the local drug scene and season-
al variations, as well as quantity estimates based upon the frequency of injection.
However, for the countries in this study, where civil society is relatively nascent and
the history of partnership between governments and NGOs is short, working togeth-
er to develop Global Fund proposals and implement projects has been challenging
to both sectors. Striking the right balance between government leadership and con-
trol is a work in progress, as is ensuring that NGOs, particularly grassroots organi-
zations led by or working with drug users, have the capacity and support necessary
to engage effectively in these processes. 
The criminalization and marginalization of drug users, along with the often
unclear legal status of providing harm reduction services in many of the countries,
is an added barrier. In Georgia, for example, one NGO described these challenges to
expanding the range of materials procured through the Global Fund project:
We wanted to expand the inventory of supplies for harm reduction to include tourniquets,
cookers or spoons, and filters. However, the incompatibility of harm reduction services
with the law and increased police enforcement made the CCM hesitate to include these
products in the proposal. They did not want to appear to be encouraging drug use. 
Another challenge is estimating the size of the target groups, since these estimates
form the basis for setting the scale of interventions, establishing coverage targets, as
well as procurement planning. Several respondents expressed concerns that these
initial estimates included in proposals were not reliable or were outdated and, there-
fore, led to inappropriate planning and implementation of activities. As a represen-
tative from an NGO in Tajikistan stated, “There are no uniform data on the estimat-
ed number of IDUs in the country and procurement is conducted on the basis of
abstract assumptions, which do not correspond to the reality.” These estimates were
based on a population study conducted by the United Nations Office on Drugs and
Crime in 2002; a new study was conducted in 2009, which will inform planning
moving forward. 
In Armenia, the principal recipient noted that “quantities estimated at the begin-
ning of the project (i.e., those included in the proposal) were probably valid for [the
first two years of project implementation] but in many instances do not match real
needs at present.” Implementing NGOs can help provide realistic assessments of
target group sizes based on the number of clients they serve; however, even these
estimates may prove unreliable due to their limited coverage areas. Size estimation
studies are needed, on a regular basis, to collect more accurate data on which CCMs
can make decisions. 
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At the point when countries should be considering how they can most effectively
fight HIV and AIDS and meeting the needs of those most at risk, inadequate epi-
demiological data and information about drug users, political imperatives and con-
straints, tensions between government representatives and NGOs, and NGOs’ own
lack of capacity to effectively engage in these processes, often end up compromising
the quality of the public health interventions that are being proposed and funded. 
Global Fund Grants: Phases of Implementation
Grant agreements are signed for an initial two years, after which, depending on perform-
ance, new agreements can be signed for the next three years of project implementation.
Countries with good-performing grants may be invited to submit applications for “rolling
continuation channel” funding. This can extend the implementation of projects, with
some changes in scale and scope, for up to another six additional years, implemented
in two three-year phases. In order to minimize interruptions in funding for grants that
are likely to be renewed through the rolling continuation channel process, the Global
Fund may provide short-term “bridge funding.” At each stage of grant renewal, country
coordinating mechanisms have the opportunity to make changes to budgets and work
plans to adjust for changing conditions on the ground. However, this requires that CCMs
perform adequate oversight over grant implementation, are aware of the challenges and
concerns, and have the political will to make changes. 
The Procurement Process: Developing Technical Specifications and
Evaluating Bids
Harm reduction supplies can be easily afforded by the beneficiaries (condoms and
syringes are widely available compared to early- and mid-1990s and they are cheap com-
pared to what the IDUs and sex workers pay for other things). The harm reduction pro-
grams in our countries should focus not on provision of full quantities required (it is
impossible anyway), but rather on the quality of products. Procurement should focus on
quality, and technical specifications need to be “advanced.” However, the Global Fund
still focuses on price.
Implementing NGO, Armenia 
The specifications of harm reduction supplies to be purchased by all principal recip-
ients are based on a combination of criteria: input from national AIDS centers,
expert evaluation, the list of products already used by subrecipients, recommended
product types, resources available, and the national essential drug list. 
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Quality requirements can be addressed most effectively by ensuring that appro-
priate standards and specifications are included in the tender solicitation documen-
tation by, for example, setting requirements to correspond with recognized interna-
tional standards. The principal recipients in Armenia and Georgia use WHO speci-
fications for procuring health commodities. International standards are considered
by the subrecipients of the Russian Health Care Foundation when developing local
specifications. However, developing technical specifications in order to ensure that
high quality supplies are procured is a skill, and jn many cases the procuring entities
still need to develop capacity and expertise in this regard. The Georgian principal
recipient noted, for example, that they have learned that there is a need to put for-
ward additional requirements in tender documents, such as manufacturing similar
goods for a minimum number of years or managing a minimum number of similar
contracts, and performing additional on-site quality control.
In some cases, implementing NGOs are involved in the development of techni-
cal specifications for harm reduction supplies; however, the extent and frequency of
their involvement varies. The principal recipient from Tajikistan reported that it col-
lected information for technical specifications from the network of harm reduction
outreach points. On the other hand, four out of five subrecipient NGOs from
Tajikistan indicated they were not consulted by the principal recipient about techni-
cal specifications. Three of the NGOs surveyed from Georgia indicated that over the
last two years, representatives of the principal recipients conducted consultations
with the NGOs regarding the technical specifications of syringes and needles. 
The majority of principal recipients consider the bid evaluation process as suffi-
ciently reliable or very reliable. According to the principal recipients, identification
and selection of products is carried out with the involvement of the principal recipi-
ents’ program managers and procurement specialists, subrecipient program man-
agers in some cases, and beneficiaries and representatives of AIDS centers. In
Georgia, the evaluation committees only include staff of the principal recipient (pro-
gram manager, procurement and supply specialist, or others). 
According to most of the NGOs surveyed, subrecipients do not take part in the
tender evaluation process. In a good practice being implemented in Armenia, how-
ever, although the NGOs are not part of the tender commissions, the principal recip-
ient asks them to give samples of the products to their clients, whose opinions are
considered prior to awarding the supply contracts. An NGO from Georgia reported
being involved a similar practice. In another case, an NGO representative in Georgia
was invited for a bid evaluation, as an observer without right to vote, so that she
could give her opinion on the samples of syringes presented by the bidders. Most
NGOs were not aware of either the evaluation procedures by the principal recipients
or of the composition of the tender commissions. This led one NGO in Georgia to
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comment, “We do not know the members of these committees, but based on pro-
curement results we can assume that they are not sufficiently qualified to evaluate
bids in a proper way.”
The supplier selection process is usually made on the basis of the lowest price, while qual-
ity of goods is not recognized as a major factor for bid award. This approach, reportedly,
is grounded in Georgia procurement and tender regulations. . . . Both quantification and
quality specifications of harm reduction products should be based on appropriate
research and our recommendations. 
Implementing NGO, Georgia
Each principal recipient uses different criteria when awarding contracts to a supplier.
However, price is the major consideration in all countries. The principal recipients
use the “best value for money” principle in evaluating bids, mostly selecting the low-
est price for a product deemed to be of acceptable quality. Technical characteristics
and quality of products are given significantly less weight than price, creating the
risk of inappropriate or poor quality products being given preference. 
While prequalification of suppliers who can submit bids is used by some princi-
pal recipients, this alone may not ensure that high quality products will be supplied.
When price is a leading factor during evaluation, even a highly qualified bidder may
opt to offer lower quality products at a lower price, in order to remain competitive.
Involving harm reduction NGOs in developing specifications or evaluating bids—
particularly in pretesting products—can be extremely beneficial in ensuring that
appropriate and high quality supplies are purchased. 
In all countries, the quantities of supplies ordered are usually based on estimates
included in the proposal initially, and then adjusted thereafter according to the con-
sumption of the products. Most NGOs are asked to give feedback on quantities of
supplies they require, either before orders are placed or after the orders have been
received. The Russian Harm Reduction Network, for example, uses a website that
allows NGOs to specify the type and quantity of supplies they need. In a good prac-
tice, the Tajik principal recipient provides NGOs with the quantities of supplies that
they request, but also stores buffer stocks at the regional level to prevent stock-outs.
NGOs point out that when principal recipients place orders based on past con-
sumption only, the orders may be inadequate to deal with changes in the drug scene,
or to allow for the scale-up of services. According to an NGO in Georgia, shortages
in supplies are experienced because “calculations are mainly based on the number
of continuous clients, while the new users are not taken into consideration.”
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Procurement in Russia
In Russia, the Russian Health Care Foundation (principal recipient of the round 4 project)
delegates procurement to the subrecipients. The subrecipients manage the entire pro-
curement cycle, and their managers on sites are mostly involved in identification as well
as estimations of necessary quantities of goods. Many subrecipients have health care
specialists as program managers. The procurement and supply management specialist
at the Russian Health Care Foundation intervenes in cases when clarifications are
needed. When subrecipients announce open competitions and receive and examine pro-
posals, Russian Health Care Foundation experts provide strategic recommendations on
selecting products and identifying the quantities required for implementation of harm
reduction projects.
Limited capacity of principal recipients and subrecipients
Another factor that potentially compromises quality during the procurement process
and project implementation is a lack of capacity, both of principal recipients and sub-
recipients, to accurately forecast needs, monitor quality, and respond when there are
challenges. 
A principal recipient from Russia noted, for example: 
We have a form that lists all the different kinds of syringes and needles that a project
might want, and they fill in the numbers of each required.  But there are times when the
NGOs say that they need 1,000 syringes of only one kind, say, 1 ml, and nothing for the
rest, and we fill those orders as they are written.  Our only problem is that we didn’t go
back and ask them why they said they needed only one kind of needle.
The principal recipient in Tajikistan reported similar problems in communication
with subrecipients about their needs. One NGO in Tajikistan expressed the need for
support from the principal recipient to help them more accurately forecast needs:
“We requested syringes for a six-month period but the quantity turned out to be suf-
ficient for one year. The principal recipient should assist us in estimating our
needs.”
Many of the NGOs we surveyed, particularly from Georgia and Tajikistan, point-
ed to the need to strengthen the principal recipients’ competence and management
capacities for effective procurement of harm reduction supplies. In particular, many
of their suggestions referred to contract administration practices, which often result
in delays in procurement and deliveries. 
2 5
Communication and Cooperation Between Implementers and Principal
Recipients
There is a need to improve and diversify the ways of getting feedback to and from the
target groups. To collect information from the clients and establish good communication
with them, different activities should be conducted: focus group discussions, opinion
polls, training, distribution of various educational materials. 
Implementing NGO, Tajikistan
There are established systems of reporting to principal recipients on the use of harm
reduction supplies in all countries. All NGOs except one responded that they regu-
larly report the quantities of supplies used to the principal recipients. However, just
over half of implementing NGOs reported that they also report on the quality of
products and timeliness of delivery. 
The frequency and format of reporting varies across the projects. In Armenia,
the subrecipients send quarterly reports to the principal recipient on quantity.
Further, quality and timeliness are addressed in the annual reports to the principal
recipient and on ad-hoc basis in case of problems. In Georgia and Tajikistan, the
NGOs report on quantities used and, in the case of Georgia, provide feedback on
quality on a monthly basis. In Russia, the frequency varies across the three projects
(monthly or quarterly). Russian NGOs also pointed out that they tend to inform the
principal recipients when problems with quality arise. In a good practice, the Open
Health Institute and Russian Harm Reduction Network perform an annual quality-
of-services survey to get the feedback of NGOs and drug users and make adjust-
ments in their programs accordingly. 
In many instances, the NGOs were not satisfied with the way their complaints
were treated. NGOs from Georgia and Tajikistan stated that their suggestions, based
on the users’ complaints, were not taken seriously or considered by the principal
recipients at all, or were considered only a few times. In some cases, the lack of
responsiveness by principal recipients has resulted in less feedback being provided
by NGOs. One NGO in Georgia stated, “We have stopped reporting on the quality of
products as so far we have not received any feedback on our complaints.” 
On the other hand, principal recipients indicated that NGOs were not always
responsive to their requests for feedback on quality or the quantities of supplies that
were needed. As one principal recipient in Russia put it:
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[The NGOs] may take a long time.  I send them an email asking them how many supplies
they will need and telling them that I have to make the big order in two weeks.  Some
of them don’t respond for four weeks.  I don’t have orders from two projects and 31 others
are waiting.
Good communication between principal recipients and implementers can ensure
rapid response to quality concerns that might undermine the effectiveness of harm
reduction projects. 
Rigidity of Global Fund Policies and Processes
The principal recipient should have more flexibility in decision making and autonomy,
and this would improve the project implementation. At the same time, this probably
depends not on the principal recipient itself, and has to involve the overall improvement
of Global Fund processes. 
Implementing NGO, Armenia
Many study participants considered that to a substantial extent the problems and
challenges faced in the field are exacerbated by the Global Fund’s rules and process-
es. Most frequently the respondents mentioned what they perceived as the lack of
flexibility during implementation. One NGO from Russia commented: “We wish
there was a way, during the implementation of the project, to change the supplied
materials depending on the situation in the field. Currently, we put through the
request for materials before the project starts, but during project implementation
clients sometimes have varying needs and exchanging one type of material for
another after the project starts is rather problematic.” 
The Global Fund’s commitment to performance-based funding means that they
must be able to monitor progress in implementation, which they do through a series
of targets and indicators that are established by CCMs and included in grant agree-
ments. In all four countries, all of the coverage and process indicators for harm
reduction services are focused on quantities (such as the number of syringes and
needles supplied or the number of drug users reached) and do not measure the qual-
ity or appropriateness of services provided. There is only one exception: in Russia,
where the Russian Harm Reduction Network is a principal recipient, one indicator
measures the “percentage of IDUs reporting satisfaction with range and quality of
services provided.” 
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Principal recipients and subrecipients identified the Global Fund’s emphasis on
quantitative process indicators, rather than quality, as a common concern. As an
NGO in Georgia said, “Often it looks like the Global Fund and principal recipient
care only about process indicators and spending money, but not about the real
impact of the project.” 
The focus on numbers suggests that the Global Fund should strengthen mech-
anisms to ensure the quality of services and products delivered to project beneficiar-
ies. This is further illustrated by the reporting arrangements for subrecipients imple-
menting harm reduction programs, as discussed previously. Reports on quantity are
regularly provided to the principal recipients by all NGOs, but only just over half of
them report on quality, and often only on an ad-hoc basis. Since quality and appro-
priateness do not influence the assessment of project performance by the Global
Fund, it may also lead principal recipients to be less concerned with complaints
about poor quality products.
Centralized Versus Decentralized Procurement 
All of the principal recipients, with the exception of the Russian Health Care
Foundation, procure harm reduction supplies centrally and provide them to the 
subrecipients of the grant for further distribution to drug users. The subrecipients
of the Russian Health Care Foundation procure their own products, in compliance
with Russian public procurement legislation, as well as the foundation’s recommen-
dations. The Open Health Institute and the Russian Harm Reduction Network also
provide subrecipients with some funding to buy additional supplies, such as bleach
and alcohol swabs that the principal recipients can not efficiently procure in bulk,
and buy small quantities of other supplies to respond to changes in demand. 
The NGOs and principal recipients surveyed had a wide range of views about
whether centralized or decentralized procurement would be the most effective way
of ensuring quality. While centralized procurement can result in economies of scale,
it can also introduce inefficiencies into the system because of its rigidity. In Georgia,
for example, the principal recipient is constrained by the countries’ procurement
policies, which allow them to conduct only one procurement process per year. 
This often results in delays in receiving supplies and also means that if they forecast
inaccurately, or if changes occur in drug consumption, then they are unable to
respond quickly. 
Complete decentralization, on the other hand, has its own set of problems: it 
can substantially increase the cost of supplies; NGOs may not have the capacity to
procure effectively; and it may not be sufficient, on its own, to ensure that higher
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quality supplies are purchased. In general, respondents were more likely to favor
decentralized procurement in Georgia and Tajikistan, where concerns about the
quality of supplies were much greater overall. 
Principal recipients often do not have the flexibility to allow a mix of centralized
and decentralized procurement. In Tajikistan, for example, the grant agreement with
the Global Fund holds the principal recipient solely responsible for procurement. 
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Conclusions and 
Recommendations
We are losing the credibility and trust from our clients, which was so difficult
to gain.
Implementing NGO, Georgia
The HIV epidemic in Eastern Europe and Central Asia continues to grow but
remains concentrated largely among injecting drug users, sex workers, and their sex-
ual partners. Harm reduction among most-at-risk groups remains a key intervention
to prevent new HIV infections, reduce HIV-related illness and death, and mitigate
the epidemic’s harmful effects on individuals, communities, and societies.
Improving the quality, availability, and appropriateness of harm reduction supplies
is an important step toward an effective and sustainable HIV response.
In all of the countries, the influx of Global Fund resources has resulted in a
marked increase in the availability of harm reduction supplies. However, conven-
tional harm reduction supplies (including syringes and condoms) are widely avail-
able over the counter in all of the countries studied, at low cost. As a result, many
drug users are now less likely to accept poor quality products, but instead have
become more selective and use products that best satisfy their preferences. 
Many study participants emphasized that poor quality products had the potential
to undermine their work. As one NGO in Georgia told us, “We lose our clients. They
refuse to use the bad quality syringes.” 
There are cases when IDUs refuse to take syringes (they say they would rather go to the
drugstore because syringes are of better quality there).
Implementing NGO, Tajikistan
The point of harm reduction services in the region is not simply to distribute clean
needles, but to develop relationships with drug users and understand the risks and
challenges they face, inform and educate drug users to help minimize their risks,
provide advice on changing behaviors, offer HIV testing, and refer them to other
essential health services, including HIV treatment. This will continue to be possible
only if NGOs have a consistent supply of appropriate and high quality products. 
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Problems with quality and appropriateness of harm reduction supplies occur
often. Overall, complaints from the end-users were documented in 73 percent of sub-
projects, and in 45 percent of these they were frequent. The complaints were mostly
about quality (64 percent); however, the drug users also found the supplies inappro-
priate for use (41 percent). At the same time, shortages or interruptions of supply
were faced less frequently (14 percent). The study findings clearly show that the key
challenge for harm reduction programs is to ensure appropriateness and high qual-
ity of harm reduction products supplied to drug users. 
In all countries, national legislation and Global Fund policies ensure the imple-
mentation of the key principles of good procurement. At the same time, there are a
variety of different arrangements across the countries for the implementation of
these principles: there are some limitations, however, in terms of accessibility of the
information to potential vendors and difficulties in applying these policies to the spe-
cific needs of procurement for the health sector. 
In general, principal recipients that were nongovernmental organizations,
including an international NGO in Armenia and two national NGOs and a noncom-
mercial partnership in Russia, appear to do better in delivering high quality supplies
to implementing NGOs and minimizing interruptions in supply. This may be due to
the fact that they have a higher level of flexibility and are less constrained by national
procurement laws and policies and UN procurement policies. They may also be
more responsive to the concerns raised by drug users through implementing NGOs. 
On the other hand, where the principal recipients were the United Nations
Development Program (Tajikistan) and a governmental department (Georgia),
implementing NGOs experienced greater problems with the quality of supplies. This
may be due to problems identified by the NGOs in terms of their limited participa-
tion in the procurement process, insufficient responsiveness to the drug users’
needs and expectations, the lack of flexibility they have in the procurement process,
and, in the view of many NGO respondents, insufficient capacity in procurement,
supply management, and contracting. 
The lack of participation of NGOs in proposal development and procurement
processes contributes to the problems with quality. The NGOs are better placed to
understand drug users’ needs and expectations, see changes in drug consumption
patterns as they occur, and also see the negative consequences that poor quality sup-
plies have on the effectiveness of their programs. Yet, particularly in Tajikistan and
Georgia, their perspectives have not always been taken into account. 
Overall, one of the biggest challenges appears to be to the focus in all countries
in procuring the lowest-cost products. The possible savings involved in procuring
the lowest-cost products, and only a narrow set of products, at the expense of quality
and diversification, may be offset by the fact that drug users are less likely to take
poor quality projects, and may be less likely to return to harm reduction services as
a result. This may undermine the long-term effectiveness and impact of the inter-
ventions on reducing HIV infections. 
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The lack of flexibility to respond to changing needs and contexts experienced 
by principal recipients while they are implementing Global Fund projects may 
contribute to problems with quality or shortages in certain supplies. The overempha-
sis by the Global Fund on meeting quantitative targets rather than ensuring quality
programming may also lead principal recipients to place less priority on quality
themselves. 
Recommendations 
To Country Coordinating Mechanisms:
t Ensure that drug users and other key affected populations and the NGOs that
work with them participate in designing Global Fund proposals and provide
feedback on the types and quantities of supplies needed, as well as assist
in target size estimations. 
t Exercise active oversight of the implementation of grants, seek feedback from
principal recipients, subrecipients, and beneficiaries on the quality of
programs and harm reduction supplies and on changing drug injection
trends, and modify programs accordingly during phase two and rolling
continuation channel requests. 
To Principal Recipients:
t Pretest needles, syringes, and other harm reduction supplies with drug users
through NGO subrecipients before awarding contracts. As is the case in
Armenia, taking into account the feedback from pretesting when making
procurement decisions will help to avoid or substantially reduce potential
problems with the quality of procured products.
t Include beneficiaries in the tender process to help determine appropriate
quantity and quality. Drug users’ needs and expectations need to be taken
into consideration when planning procurement of harm reduction
supplies; they should in fact “drive” the procurement process.
t Allocate funds for partial decentralization of procurement to the project
subrecipients. A certain percentage of the overall budget should be
available for low-cost products that are available locally and for which
organization of a centralized procurement procedure is not expedient.
Partial decentralization will also allow projects to respond more effec-
tively to injection drug users’ changing needs and safeguard against
possible interruptions in commodity supply. In such cases, the project
should establish reliable procedures to hold subrecipients accountable
and promote transparency. 
t Plan biannual or more frequent procurement of needles and syringes, to ensure
that changes in drug use patterns or user preferences can be accommo-
dated and minimize costs for storage and security.
3 2 Buyer Beware? Global Fund Grants and Procurement of Harm Reduction Supplies in Eastern Europe and Central Asia
t Allocate funding to subrecipients to cover delivery, storage, and security when
shipping large numbers of needles and syringes or procuring infre-
quently.
t Ensure that client satisfaction surveys are a routine component of the
project work-plans. 
To Subrecipients:
t Submit formal, written accounts of procurement issues, with a request for
written follow-up.
t Be aware of procurement schedules and requirements for timely completion
of forms to avoid creating regional or countrywide delays. 
To the Global Fund Secretariat: 
t Ensure that indicators on quality of harm reduction services, as well as the
quantity of services provided, are included in grant agreements and taken
into account when evaluating quarterly reports. 
t Ensure that client satisfaction surveys are a routine component of the
project work-plans.
t Ensure that principal recipients have a system for proper evaluation and follow-
up of the beneficiaries’ complaints regarding harm reduction services
and supplies.
t Revise the procurement guidelines to emphasize the importance of procuring
quality supplies. 
t Compile a brief guide/checklist on good procurement practices for recipients
of harm reduction grants.
t Meet with drug users and harm reduction NGOs during country visits, as
well as principal recipients, to discuss the quality of services that are
being provided and make recommendations accordingly. 
t Require that Local Fund Agents perform quality checks of products that are
procured with Global Fund resources, as well as verify financial and
programmatic data. 
To the Global Fund Board:
t Consider developing a quality assurance strategy for health commodities,
including needles and syringes and other supplies. 
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In Eastern Europe and Central Asia, where the HIV epidemic is concentrated
largely among injection drug users, harm reduction programs are crucial to pre-
vent new HIV infections and reduce illness and death. Support from the Global
Fund to Fight AIDS, Tuberculosis and Malaria has been instrumental in increas-
ing the availability of harm reduction services and supplies, such as clean needles
and syringes. However, harm reduction organizations in the region are con-
fronting an influx of poor-quality supplies that threatens the success of their pro-
grams. Improving the quality of supplies is an important step toward an effective
and sustainable HIV response.
